Welcome to
RBP World!
Drugs target to NCBP2
Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
---|---|---|---|---|---|---|
OBEFAZIMOD | Small molecule | ulcerative colitis | Cap binding complex modulator | 2.0 | Recruiting | ClinicalTrials |
OBEFAZIMOD | Small molecule | ulcerative colitis | Cap binding complex modulator | 2.0 | Active, not recruiting | ClinicalTrials |
OBEFAZIMOD | Small molecule | ulcerative colitis | Cap binding complex modulator | 2.0 | Completed | ClinicalTrials |
OBEFAZIMOD | Small molecule | ulcerative colitis | Cap binding complex modulator | 3.0 | Recruiting | ClinicalTrials |
OBEFAZIMOD | Small molecule | HIV infection | Cap binding complex modulator | 1.0 | Completed | ClinicalTrials |
OBEFAZIMOD | Small molecule | COVID-19 | Cap binding complex modulator | 2.0 | Terminated | ClinicalTrials |
OBEFAZIMOD | Small molecule | rheumatoid arthritis | Cap binding complex modulator | 2.0 | Completed | ClinicalTrials |
OBEFAZIMOD | Small molecule | rheumatoid arthritis | Cap binding complex modulator | 2.0 | Active, not recruiting | ClinicalTrials |
OBEFAZIMOD | Small molecule | HIV infection | Cap binding complex modulator | 2.0 | Completed | ClinicalTrials |
OBEFAZIMOD | Small molecule | ulcerative colitis | Cap binding complex modulator | 3.0 | Not yet recruiting | ClinicalTrials |
OBEFAZIMOD | Small molecule | Crohn's disease | Cap binding complex modulator | 2.0 | Not yet recruiting | ClinicalTrials |